ContraFect Corporation (CFRX) Stock Analysis
DELISTED 2023
What happened to ContraFect Corporation (CFRX) stock?
ContraFect Corporation (CFRX) no longer trades on public markets. It was delisted in November 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- November 2023
- Last recorded price (historical):
- $0.05 (last quote on record before the November 2023 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
ContraFect Corporation (CFRX). ContraFect Corporation is a clinical-stage biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases.
Last analyzed: May 10, 2026ContraFect Corporation (CFRX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy CFRX shares?
No. CFRX stopped trading on public markets in November 2023, so the shares are not available through a broker. Anything you see quoted for CFRX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before CFRX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to ContraFect Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.